MARTA MARIA
GARCIA CLEMENTE
Profesora Asociada en CC. Salud - LOSU
Hospital de Cruces
Barakaldo, EspañaPublicaciones en colaboración con investigadores/as de Hospital de Cruces (14)
2024
-
Analysis of the Evolution of Tuberculosis in Men and Women in Spain Between 2017 and 2022. Is There a Different Incidence Decline by Gender?
Archivos de Bronconeumologia, Vol. 60, Núm. 5, pp. 312-315
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease
Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 556-565
2022
-
Effectiveness and Safety of Inhaled Antibiotics in Patients With Chronic Obstructive Pulmonary Disease. A Multicentre Observational Study
Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. 11-21
-
Real Life With Tezacaftor and Ivacaftor in Adult Patients With Cystic Fibrosis: Spanish Multicenter Study
Archivos de Bronconeumologia, Vol. 58, Núm. 9, pp. 672-674
2021
-
C-Reactive Protein Concentration in Steady-State Bronchiectasis: Prognostic Value of Future Severe Exacerbations. Data From the Spanish Registry of Bronchiectasis (RIBRON)
Archivos de Bronconeumologia, Vol. 57, Núm. 1, pp. 21-27
-
Study of the Diagnostic Delay of Tuberculosis in Spain
Archivos de Bronconeumologia
2020
-
Consensus Document on the Diagnosis and Treatment of Chronic Bronchial Infection in Chronic Obstructive Pulmonary Disease
Archivos de Bronconeumologia, Vol. 56, Núm. 10, pp. 651-664
-
Evaluation of the Integrated Tuberculosis Research Program Sponsored by the Spanish Society of Pulmonology and Thoracic Surgery: 11 Years on
Archivos de Bronconeumologia, Vol. 56, Núm. 8, pp. 483-492
-
Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey
Respiratory Medicine, Vol. 170
-
Study of the Diagnostic Delay of Tuberculosis in Spain
Archivos de Bronconeumologia
-
Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January–April 2020
Emerging Infectious Diseases, Vol. 26, Núm. 11, pp. 2709-2712
2018
-
Cost of hospitalizations due to exacerbation in patients with non-cystic fibrosis bronchiectasis
Respiration, Vol. 96, Núm. 5, pp. 406-416
2016
-
Factors associated with fatality during the intensive phase of anti-tuberculosis treatment
PLoS ONE, Vol. 11, Núm. 8